Partner at Cerity Partners
Member since: Oct '21 · 333 Opinions
His best performer so far this year, up 12%. Well-managed. They replaced Humira with hit drugs and added key companies; pays a 3.2% dividend.
Fuel prices are now low, there's no labour contracts up for negotiation and plane travel demand is high. Also, the PE is now attractive. His pick is DAL in this space. They will probably earn $7.50 this year and $8.50 next. Make sense to put a 10x multiple on it.
He's overweight healthcare and within that is overweight biotech and pharma. There's a reversion to the mean after a brutal election year, but that's always the case. Relief comes when presidential policies are not as dire as expected. These stock have tremendous valuations and pay good dividends and there's growth with aging demographics.
He thinks NVDA will move 10% to the upside, and yes this is a pivotal moment. It's hard to see demand falling off. It trades at 30x forward PE with net income growth and EPS growth over 100% YOY, with forward projections up 50%. At 30x forward PE and that projection, NVDA is very attractive. True, stocks can always go done, and in the past quarters, NVDA announces fabulous earnings and the stock has gone down. So, how NVDA trades tomorrow and Friday doesn't matter. Given this valuation and insatiable demand, he'll take that 10% higher.
Watch for the decline on revenues from China YOY, but the worse has been priced in already.
He expects a weak quarter on Thursday. Share prices are falling due to farmer incomes, which should turn around. Price crops should increase. Deere has controlled inventory.
The price hikes must stop at the theme parks and focus on getting more people into them. It's good to hold now, because of the valuation and streaming is more profitable than it was projected a year ago.
Is soaring on Trump's steel tariffs, but is -42% the past year. But it comes down to steel prices. He won't sell a share. They've made good acquisitions, and control costs well.
He bought more. 14x forward PE and pays a 2.3% dividend yield. Good value. The ARM lawsuit was an overhang, but now resolved in QCOM's favour. This and the semis saw momentum in the first half of 2024. Business fundamentals remain intact; only QCOM can serve certain AI applications. Likes it for the long run.
Doesn't see anyone killing the F-35 program.
Bearish. We're well into password-crackdown/sharing and the ad tier. Analysts may be pricing in too many good things to this name than can actually happen.
Though up 139% this year, there's still room to run. The estimates are too long. Sales estimates for 2025 have not budged for the past 9 months. Makes no sense when you look at passenger volumes and increase in ticket prices. Meanwhile, jet fuel prices have fallen. Earnings must go higher than priced in now.
He hates to say this, but the world will remain a violent place.
A definite hold, though you can probably add to it here. It reports Thursday and he wants to hear how the streaming business is going, and are the theme parks recovering. A lot of things
He bought more today on the dip. Trades at 24x earnings, expecting that to grow 50% this year. The growth rate will one day drop off, but now now. It boasted a triple beat and remains the leader of semis.